Work

Heterogeneity of BCG unresponsive bladder cancer clinical trials limits patients’ access to novel therapeutics.

Year: 2022

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2022.40.6_suppl.572

Authors: Michael Chandra, Debasish Sundi, Kamal S. Pohar, William Edgar Carson, Roger Li

Institutions: The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, The Ohio State University, Moffitt Cancer Center

Language: English

Topic: Bladder and Urothelial Cancer Treatments

Subfield: Surgery

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4213231849

Cites:

Cited by:

Related to: 10